All News | FDA

Advertising & Promotion

Jan 23, 2015
Senator Pushes Bill Penalizing Big Drug Companies for Settling Federal Allegations
Jan 22, 2015
Draft Device Guidance Ties Accessory Classification to Marketing Materials
Jan 14, 2015
Daiichi Sankyo Pays $39 Million To Settle Kickback Allegations
Jan 13, 2015
CVM Challenges Antibiotic Claims in Rare Warning Letter Over Promotion
Jan 13, 2015
Planned Study on Shortened Major Statement Headed to OMB Review
Jan 7, 2015
CDER Plans Six Advertising-specific Guidances for 2015
Dec 20, 2014
FDA Planned Review of Off-label Policies Is ‘Front Burner’ Issue for CDER in 2015
Dec 18, 2014
Untitled Letter Blasts Sunovion Over Efficacy Claims in Print Ad
Dec 9, 2014
OtisMed, CEO Plead Guilty to Selling Thousands of Uncleared Surgical Devices
Dec 3, 2014
Grand Jury Indicts Device Manufacturer, CEO, Alleging Off-label Marketing, Conspiracy To Defraud

Good Clinical Practice

Jun 18, 2016
FDA Suggests Ways To Boost Subgroup Enrollment
Jun 18, 2016
FDA Issues Draft Guidance on Evaluating and Reporting Age, Race, Ethnicity Data for Device Trials
Jun 17, 2016
FDA and NIH To Conduct Pediatric Clinical Investigator Training in September
Jun 15, 2016
Exclusion Criteria for Type 2 Diabetes Trials May Impede Enrollment of Women
Jun 15, 2016
Survey Finds Less Resistance to Trial Subjects Using Own Devices for PRO
Jun 14, 2016
FDA Posts Videos To Launch Program Encouraging Minority Trial Participation
Jun 14, 2016
Researchers Find Patient-Developed Consent Forms Are Shorter, Better Understood
Jun 13, 2016
Canadian Medical Groups Endorse Consensus Framework for Ethical Collaboration
Jun 13, 2016
Companies Should Provide Public Disclosure Schedules When Seeking EU Market Authorization
Jun 3, 2016
S.C. Governor Signs ‘Right-to-Try’ Bill

FDA Regulation & Enforcement

Feb 25, 2019
Senate Finance Leaders Question Insulin Price Increases
Feb 25, 2019
Senator Questions FDA on Opioid Marketing
Feb 20, 2019
Shipments of Unsolicited Drugs by Compounding Pharmacy in Florida Lead to False Claims Act Settlement
Feb 20, 2019
AMS Proposes To Add, Reclassify Substances on National Organic List
Feb 20, 2019
Draft Guidance Shows How To Request Nonbinding FDA Feedback Following a Device Establishment Inspection
Feb 16, 2019
Oregon Bill Would Require Wholesale Price Disclosure in Drug Ads
Feb 16, 2019
Whistleblower Takes Gilead To Court Over Its FOCUS Program
Feb 15, 2019
Study Finds Industry Payments To Cancer Physicians Over Time Increase Prescribing Rates
Feb 14, 2019
FDA Finalizes Guidance on Public Warnings, Notifications Following Recalls of Violative Products
Feb 14, 2019
FDA Begins Efforts To ‘Modernize’ Dietary Supplement Oversight

Copyright © Thompson FDA, a division of CBIS. All rights reserved.